Aurinia Suspends Voclosporin Development For Dry Eye, Staying Focused On Lupus

Biotech doesn’t shut the door on returning to ophthalmic formulation of the calcineurin inhibitor in dry eye but puts primary focus on oral voclosporin in lupus nephritis, with an FDA approval decision imminent.

Female eye with long eyelashes close up. Closeup shot of female gray - blue colour eye with day makeup. Beauty female eye with curl long eyelashes
With disappointing data, Aurinia is dropping dry eye development to focus on lupus nephritis

More from Clinical Trials

More from R&D